EYPT

News This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

14d ago

News EyePoint Pharmaceuticals GAAP EPS of -$0.99 misses by $0.19, revenue of $0.7M beats by $0.35M

27d ago

News EyePoint Pharmaceuticals Q1 2026 Earnings Preview

28d ago

Insider trade Sale by Ramiro Ribeiro (Chief Medical Officer)

39d ago

Insider trade Sale by Ramiro Ribeiro (Chief Medical Officer)

42d ago

News EyePoint sues Ocular over claims related to lead asset

73d ago

Insider trade Purchase by Jay S. Duker (President and CEO)

77d ago

Insider trade Sale by Ramiro Ribeiro (Chief Medical Officer)

88d ago

News EyePoint outlines mid-2026 topline data target for DURAVYU in wet AMD and DME as Phase III trials advance

89d ago

News EyePoint Pharmaceuticals GAAP EPS of -$0.81 misses by $0.08, revenue of $0.62M misses by $0.39M

90d ago

Short volume Short volume 58% of volume (5.3σ)

118d ago

News FDA In Brief: Findings from Real-World Data Study Reveal Higher Risk of Hospitalization and Death Among Cancer Patients with COVID-19, Underscore Health Disparities

119d ago

News EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

137d ago

Insider trade Sale by Ribeiro Ramiro (Chief Medical Officer)

145d ago

News EyePoint Reports Corporate Update and Anticipated Pivotal Milestones for 2026

146d ago

News EyePoint Announces Pricing of Public Offering

153d ago

News Gilead's HIV Drugs Power Earnings Beat, Company Eyes Multiple Launches By 2026

153d ago

Scanner Unusual volume (z=7.1)

160d ago

Scanner Unusual volume (z=7.0)

163d ago

Scanner Unusual volume (z=7.0)

164d ago

News Hungary Holds Key Rate as Investors Eye New Inflation Projection

168d ago

News EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

168d ago